Breast Cancer Clinical Trial

Efficacy and Safety of BMS-690514 in Combination With Letrozole to Treat Metastatic Breast Cancer

Summary

The purpose of this study is to determine if BMS-690514 + letrozole will be more effective than lapatinib + letrozole in patients who have metastatic hormone receptor positive breast cancer after developing progressive disease immediately following adjuvant antiendocrine therapy

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Documented invasive breast cancer
Greater than 10% tumor cells positive for estrogen receptor and/or progesterone receptor
HER2+ and HER2- (Human Epidermal growth factor Receptor) disease
Rapid disease progression despite treatment with tamoxifen, anastrozole or exemestane
ECOG Performance status = 0 or 1

Exclusion Criteria:

Prior hormonal therapy for metastatic disease
Prior hormonal therapy with letrozole for adjuvant disease
Symptomatic brain metastases
Prior treatment with any tyrosine kinase inhibitor

Study is for people with:

Breast Cancer

Phase:

Phase 2

Estimated Enrollment:

4

Study ID:

NCT01068704

Recruitment Status:

Completed

Sponsor:

Bristol-Myers Squibb

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 8 Locations for this study

See Locations Near You

Texas Oncology-Abilene
Abilene Texas, 79606, United States
Texas Oncology-Beaumont
Beaumont Texas, 77702, United States
Us Oncology Central Pharmacy
Fort Worth Texas, 76177, United States
Yakima Valley Memorial Hospital/North Star Lodge
Yakima Washington, 98902, United States
Local Institution
Rosario Santa Fe, S2000, Argentina
Local Institution
La Rioja , 5300, Argentina
Local Institution
Colima , 28030, Mexico
Local Institution
Lima , 34, Peru

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 2

Estimated Enrollment:

4

Study ID:

NCT01068704

Recruitment Status:

Completed

Sponsor:


Bristol-Myers Squibb

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider